Zheng SE - Search Results

1

The expression of CRM1 is associated with prognosis in human osteosarcoma.

Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Chen P, Sun YJ, Tang LN, Zheng SE. Yao Y, et al. Among authors: zheng se. Oncol Rep. 2009 Jan;21(1):229-35. Oncol Rep. 2009. PMID: 19082467

2

Down-regulation of ribosomal protein L7A in human osteosarcoma.

Zheng SE, Yao Y, Dong Y, Lin F, Zhao H, Shen Z, Sun YJ, Tang LN. Zheng SE, et al. J Cancer Res Clin Oncol. 2009 Aug;135(8):1025-31. doi: 10.1007/s00432-008-0538-4. Epub 2009 Jan 6. J Cancer Res Clin Oncol. 2009. PMID: 19125294

3

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.

Lin F, Zheng SE, Shen Z, Tang LN, Chen P, Sun YJ, Zhao H, Yao Y. Lin F, et al. Among authors: zheng se. Med Oncol. 2011 Jun;28(2):649-53. doi: 10.1007/s12032-010-9493-4. Epub 2010 Mar 27. Med Oncol. 2011. PMID: 20349215

4

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide.

Lin F, Wang Q, Yu W, Tang L, Zheng S, Sun Y, Shen Z, Yao Y, Dong Y. Lin F, et al. Asia Pac J Clin Oncol. 2011 Sep;7(3):270-5. doi: 10.1111/j.1743-7563.2011.01406.x. Asia Pac J Clin Oncol. 2011. PMID: 21884438

5

Pirarubicin inhibits multidrug-resistant osteosarcoma cell proliferation through induction of G2/M phase cell cycle arrest.

Zheng SE, Xiong S, Lin F, Qiao GL, Feng T, Shen Z, Min DL, Zhang CL, Yao Y. Zheng SE, et al. Acta Pharmacol Sin. 2012 Jun;33(6):832-8. doi: 10.1038/aps.2012.20. Epub 2012 May 14. Acta Pharmacol Sin. 2012. PMID: 22580740 Free PMC article.

6

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.

Min D, Lin F, Shen Z, Zheng S, Tan L, Yu W, Yao Y. Min D, et al. Asia Pac J Clin Oncol. 2013 Mar;9(1):71-9. doi: 10.1111/j.1743-7563.2012.01560.x. Epub 2012 Jul 23. Asia Pac J Clin Oncol. 2013. PMID: 22897971

7

Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: experience of a single institution.

Han K, Sun Y, Zhang J, He A, Zheng S, Shen Z, Yao Y. Han K, et al. Asia Pac J Clin Oncol. 2014 Jun;10(2):e114-7. doi: 10.1111/ajco.12018. Epub 2012 Nov 26. Asia Pac J Clin Oncol. 2014. PMID: 23176372 Clinical Trial.

8

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.

Li H, Min D, Zhao H, Wang Z, Qi W, Zheng S, Tang L, He A, Sun Y, Yao Y, Shen Z. Li H, et al. PLoS One. 2013 Jun 21;8(6):e64513. doi: 10.1371/journal.pone.0064513. Print 2013. PLoS One. 2013. PMID: 23805177 Free PMC article. Review.

9

Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.

Yu W, Zhang Z, Min D, Yang Q, Du X, Tang L, Lin F, Sun Y, Zhao H, Zheng S, He A, Li H, Yao Y, Shen Z. Yu W, et al. Eur J Cancer. 2014 Apr;50(6):1125-36. doi: 10.1016/j.ejca.2014.01.030. Epub 2014 Feb 21. Eur J Cancer. 2014. PMID: 24565852

10

KLF8 knockdown suppresses proliferation and invasion in human osteosarcoma cells.

Lin F, Shen Z, Tang LN, Zheng SE, Sun YJ, Min DL, Yao Y. Lin F, et al. Among authors: zheng se. Mol Med Rep. 2014 May;9(5):1613-7. doi: 10.3892/mmr.2014.2027. Epub 2014 Mar 7. Mol Med Rep. 2014. PMID: 24604387 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters